ANILKUMAR PILLAI: Open Payments
NPI 1578519658 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 48 payments from 15 companies in 2025. Trend: 2023 $1,256 · 2024 $1,195 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $204 |
| Amgen Inc. | 10 | $187 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $148 |
| BETA BIONICS, INC. | 1 | $119 |
| Novo Nordisk Inc | 5 | $109 |
| PFIZER INC. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Lilly USA, LLC | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $32 |
Products named: CAPLYTA, Kerendia, iLet Bionic Pancreas, EVENITY, Wegovy, OTEZLA, FARXIGA, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
